Screener
Krystal Biotech, Inc. KRYS Net debt / EBITDA
Net debt / EBITDA at other companies
Other financials
Where this comes from
Calculated from Krystal Biotech, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026. Open the filing →
- Filed
- May 4, 2026, 7:06 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001711279-26-000043
FAQ
- What is Krystal Biotech, Inc.'s net debt / EBITDA?
- Krystal Biotech, Inc. (KRYS) reported net debt / EBITDA of -2.7× in Q1 2026.
- How has Krystal Biotech, Inc.'s net debt / EBITDA changed year-over-year?
- Krystal Biotech, Inc.'s net debt / EBITDA decreased by 2.2% year-over-year, from -2.6× to -2.7×.
- What does net debt / EBITDA mean?
- Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.
Ask your AI about Krystal Biotech, Inc.'s net debt / ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude